Panel Discussion: Bridging the Innovation-Impact Gap: What Will Define the Next Decade of Dermatology Drug Development?
Time: 2:30 pm
day: Day Two PM
Details:
• How will new modalities (gene therapy, senotherapeutics, trispecifics) reshape
pipelines?
• What breakthroughs are needed to close the 80% treatment gap?
• How can we institutionalize patient-centric, implementation-first drug design?
• What changes are coming from FDA and EMA regarding animal testing, inclusion
criteria, and biomarkers?
• Who's responsible for driving system-wide adoption: industry, academia, or policy?
